[
  {
    "ts": null,
    "headline": "Everest Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "Everest Medicines (HKEX 1952.HK, \"Everest\", or the \"Company\"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that Ian Woo, President and Chief Financial Officer, will present a company update and that the management team including chairman Bill Wu and Chief Executive Officer Rogers Luo will participate in one-on-one meetings at the 44th Annual J.P. Morgan Healthcare Conference being hel",
    "url": "https://finnhub.io/api/news?id=908fd989c522460993a0e87fdc83d648c78720ff3876665623a85597cac407b2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767657300,
      "headline": "Everest Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference",
      "id": 137997647,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "Everest Medicines (HKEX 1952.HK, \"Everest\", or the \"Company\"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that Ian Woo, President and Chief Financial Officer, will present a company update and that the management team including chairman Bill Wu and Chief Executive Officer Rogers Luo will participate in one-on-one meetings at the 44th Annual J.P. Morgan Healthcare Conference being hel",
      "url": "https://finnhub.io/api/news?id=908fd989c522460993a0e87fdc83d648c78720ff3876665623a85597cac407b2"
    }
  },
  {
    "ts": null,
    "headline": "Markets Risk-On with Venezuela News, Deregulation",
    "summary": "The Dow reached the close at 48,977 -- a record-high level. The blue-chip index gained +594 points on the day.",
    "url": "https://finnhub.io/api/news?id=441ec61d6fbc5dd57b36b3e5b807436e9413e2bf43970e9938e5e6591545774d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767653760,
      "headline": "Markets Risk-On with Venezuela News, Deregulation",
      "id": 137997648,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "The Dow reached the close at 48,977 -- a record-high level. The blue-chip index gained +594 points on the day.",
      "url": "https://finnhub.io/api/news?id=441ec61d6fbc5dd57b36b3e5b807436e9413e2bf43970e9938e5e6591545774d"
    }
  },
  {
    "ts": null,
    "headline": "Investors Expect the Market to Keep Rallying This Year",
    "summary": "3.7% That's how much Bank of America expects the S&P 500 to increase in 2026. JPMorgan Chase and Goldman Sachs expect the index to rise more. Should the S&P 500 climb for a fourth consecutive year, it would be the longest such streak since 2007.",
    "url": "https://finnhub.io/api/news?id=f204808d384c3b48df9df3d8e876a72a247b16fecdbbf74896c22160ad09a1c9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767602702,
      "headline": "Investors Expect the Market to Keep Rallying This Year",
      "id": 137991085,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "3.7% That's how much Bank of America expects the S&P 500 to increase in 2026. JPMorgan Chase and Goldman Sachs expect the index to rise more. Should the S&P 500 climb for a fourth consecutive year, it would be the longest such streak since 2007.",
      "url": "https://finnhub.io/api/news?id=f204808d384c3b48df9df3d8e876a72a247b16fecdbbf74896c22160ad09a1c9"
    }
  },
  {
    "ts": null,
    "headline": "The Dow Hits a Record Close",
    "summary": "The Dow Jones Industrial Average got its first all-time high of 2026—but fell just short of closing above 49000 for the first time.  The index was up as much as 1.7% in midday trading, then faded a bit to end the day at 48977.18, up 1.2%.  The move to a new closing high came in part thanks to a jump in shares of Chevron, the sole remaining U.S. oil major in Venezuela.",
    "url": "https://finnhub.io/api/news?id=8bdef4efc5d5ebefb2954463cc03baa23121d8eb4ae8a5d146796442b3a7e9fe",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767650627,
      "headline": "The Dow Hits a Record Close",
      "id": 137997650,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "The Dow Jones Industrial Average got its first all-time high of 2026—but fell just short of closing above 49000 for the first time.  The index was up as much as 1.7% in midday trading, then faded a bit to end the day at 48977.18, up 1.2%.  The move to a new closing high came in part thanks to a jump in shares of Chevron, the sole remaining U.S. oil major in Venezuela.",
      "url": "https://finnhub.io/api/news?id=8bdef4efc5d5ebefb2954463cc03baa23121d8eb4ae8a5d146796442b3a7e9fe"
    }
  },
  {
    "ts": null,
    "headline": "Mettler-Toledo International Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "COLUMBUS, Ohio, January 05, 2026--Mettler-Toledo International Inc. (NYSE: MTD) today announced it will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, California on Monday, January 12, 2026 at 4:30 p.m. Pacific Standard Time. A live webcast of the presentation will be available on the Company’s investor relations website at investor.mt.com.",
    "url": "https://finnhub.io/api/news?id=176a63d45155b192f14461dec1f5a2167a6a7e624728ec833c4f9a343cb3c688",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767648600,
      "headline": "Mettler-Toledo International Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference",
      "id": 137997651,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "COLUMBUS, Ohio, January 05, 2026--Mettler-Toledo International Inc. (NYSE: MTD) today announced it will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, California on Monday, January 12, 2026 at 4:30 p.m. Pacific Standard Time. A live webcast of the presentation will be available on the Company’s investor relations website at investor.mt.com.",
      "url": "https://finnhub.io/api/news?id=176a63d45155b192f14461dec1f5a2167a6a7e624728ec833c4f9a343cb3c688"
    }
  },
  {
    "ts": null,
    "headline": "Danaher to Present at J.P. Morgan Healthcare Conference",
    "summary": "Danaher Corporation (NYSE: DHR) announced that its President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P. Morgan Healthcare Conference in San Francisco, California on Tuesday, January 13, 2026 at 11:15 a.m. PT. The event will be simultaneously webcast and can be accessed on the \"Investors\" section of Danaher's website, www.danaher.com, under the subheading \"Events & Presentations.\"",
    "url": "https://finnhub.io/api/news?id=84e552752cd852dcf8a7d0a87c1aa47c6be684fa304629dabe1964f54a1ee500",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767647700,
      "headline": "Danaher to Present at J.P. Morgan Healthcare Conference",
      "id": 137997652,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "Danaher Corporation (NYSE: DHR) announced that its President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P. Morgan Healthcare Conference in San Francisco, California on Tuesday, January 13, 2026 at 11:15 a.m. PT. The event will be simultaneously webcast and can be accessed on the \"Investors\" section of Danaher's website, www.danaher.com, under the subheading \"Events & Presentations.\"",
      "url": "https://finnhub.io/api/news?id=84e552752cd852dcf8a7d0a87c1aa47c6be684fa304629dabe1964f54a1ee500"
    }
  },
  {
    "ts": null,
    "headline": "CONMED Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "LARGO, Fla., January 05, 2026--CONMED Corporation (NYSE: CNMD) today announced that Patrick J. Beyer, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference at 3:00 p.m. PT (6:00 p.m. ET) on Monday, January 12, 2026 in San Francisco, CA.",
    "url": "https://finnhub.io/api/news?id=5990121fff229ee5177ce85abae959fb2c91ea8682eb9b9e27d283d67907a579",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767647400,
      "headline": "CONMED Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference",
      "id": 137997653,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "LARGO, Fla., January 05, 2026--CONMED Corporation (NYSE: CNMD) today announced that Patrick J. Beyer, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference at 3:00 p.m. PT (6:00 p.m. ET) on Monday, January 12, 2026 in San Francisco, CA.",
      "url": "https://finnhub.io/api/news?id=5990121fff229ee5177ce85abae959fb2c91ea8682eb9b9e27d283d67907a579"
    }
  },
  {
    "ts": null,
    "headline": "Revolution Medicines to Present at 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "REDWOOD CITY, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that Mark A. Goldsmith, M.D., Ph.D., the company’s chief executive officer and chairman, will deliver a corporate presentation as part of the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 10:30 a.m. PT. To access the live webcast of the presenta",
    "url": "https://finnhub.io/api/news?id=9a6ade2dcb47e33e3619af47999782b16f471b3c7f43524452d886ae4f2d05f4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767647100,
      "headline": "Revolution Medicines to Present at 44th Annual J.P. Morgan Healthcare Conference",
      "id": 137997654,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "REDWOOD CITY, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that Mark A. Goldsmith, M.D., Ph.D., the company’s chief executive officer and chairman, will deliver a corporate presentation as part of the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 10:30 a.m. PT. To access the live webcast of the presenta",
      "url": "https://finnhub.io/api/news?id=9a6ade2dcb47e33e3619af47999782b16f471b3c7f43524452d886ae4f2d05f4"
    }
  },
  {
    "ts": null,
    "headline": "Viking Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "Viking Therapeutics, Inc. (\"Viking\") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that its chief executive officer, Brian Lian, Ph.D., will deliver a corporate presentation at the 44th Annual J.P. Morgan Healthcare Conference. The conference will take place January 12-15, 2026, in San Francisco, California.",
    "url": "https://finnhub.io/api/news?id=7546ba6244e03efd3375d521e543e4068692278df8dbe3e022a70e43c10d9476",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767646980,
      "headline": "Viking Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference",
      "id": 137997655,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "Viking Therapeutics, Inc. (\"Viking\") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that its chief executive officer, Brian Lian, Ph.D., will deliver a corporate presentation at the 44th Annual J.P. Morgan Healthcare Conference. The conference will take place January 12-15, 2026, in San Francisco, California.",
      "url": "https://finnhub.io/api/news?id=7546ba6244e03efd3375d521e543e4068692278df8dbe3e022a70e43c10d9476"
    }
  },
  {
    "ts": null,
    "headline": "Sector Update: Financial Stocks Rise Late Afternoon",
    "summary": "Financial stocks were advancing in late Monday trading, with the NYSE Financial Index rising 2% and",
    "url": "https://finnhub.io/api/news?id=59d314e817feebc9c451da4d00bfc5e063288f803d860c5bad5504ce4901ccd2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767646285,
      "headline": "Sector Update: Financial Stocks Rise Late Afternoon",
      "id": 137997656,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "Financial stocks were advancing in late Monday trading, with the NYSE Financial Index rising 2% and",
      "url": "https://finnhub.io/api/news?id=59d314e817feebc9c451da4d00bfc5e063288f803d860c5bad5504ce4901ccd2"
    }
  },
  {
    "ts": null,
    "headline": "Equify Financial Secures $100 Million Capital Facility with JPMorgan Chase & Co. to Expand Commercial Lending Platform",
    "summary": "FORT WORTH, Texas, January 05, 2026--Equify Financial announced today that it has closed a $100 million capital facility with JPMorgan Chase & Co., strengthening its balance sheet and expanding its capacity to serve middle-market businesses across the United States.",
    "url": "https://finnhub.io/api/news?id=477e38004b0f69481822eee0ee0fd025b64b2faee9c120a5ba9303c0e630b984",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767644160,
      "headline": "Equify Financial Secures $100 Million Capital Facility with JPMorgan Chase & Co. to Expand Commercial Lending Platform",
      "id": 137997657,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "FORT WORTH, Texas, January 05, 2026--Equify Financial announced today that it has closed a $100 million capital facility with JPMorgan Chase & Co., strengthening its balance sheet and expanding its capacity to serve middle-market businesses across the United States.",
      "url": "https://finnhub.io/api/news?id=477e38004b0f69481822eee0ee0fd025b64b2faee9c120a5ba9303c0e630b984"
    }
  },
  {
    "ts": null,
    "headline": "How The Subsea 7 (OB:SUBC) Story Is Shifting With New Targets And Contract Wins",
    "summary": "Subsea 7’s fair value estimate has been revised to NOK 228.39, while the Street target has been adjusted to NOK 208, leaving a modest gap that both bullish and cautious voices are now debating. Supportive analysts see this as a fine tuning of expectations and a sign that the long term story remains intact, while more conservative views treat the lower target as a reminder that execution on revenue still needs to be proven. As these signals continue to shift, it is worth keeping an eye on how...",
    "url": "https://finnhub.io/api/news?id=4bea6944fbbca946007ee55b4a19c4640f9e478c7c37f13a52c7b3dd8cb41d06",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767643731,
      "headline": "How The Subsea 7 (OB:SUBC) Story Is Shifting With New Targets And Contract Wins",
      "id": 137997658,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "Subsea 7’s fair value estimate has been revised to NOK 228.39, while the Street target has been adjusted to NOK 208, leaving a modest gap that both bullish and cautious voices are now debating. Supportive analysts see this as a fine tuning of expectations and a sign that the long term story remains intact, while more conservative views treat the lower target as a reminder that execution on revenue still needs to be proven. As these signals continue to shift, it is worth keeping an eye on how...",
      "url": "https://finnhub.io/api/news?id=4bea6944fbbca946007ee55b4a19c4640f9e478c7c37f13a52c7b3dd8cb41d06"
    }
  },
  {
    "ts": null,
    "headline": "How JPMorganChase plans to jolt 'on-chain' finance",
    "summary": "The bank's Kinexys blockchain unit processes a fraction of the institution's overall payment volume. It's betting that an appetite for the technology's promise of speedy processing and liquidity will make that larger.",
    "url": "https://finnhub.io/api/news?id=a1d612fbb948fe61fc5b4cf84ba8b6d075899db014d2586905a2f485309112c9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767641135,
      "headline": "How JPMorganChase plans to jolt 'on-chain' finance",
      "id": 137997659,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "The bank's Kinexys blockchain unit processes a fraction of the institution's overall payment volume. It's betting that an appetite for the technology's promise of speedy processing and liquidity will make that larger.",
      "url": "https://finnhub.io/api/news?id=a1d612fbb948fe61fc5b4cf84ba8b6d075899db014d2586905a2f485309112c9"
    }
  },
  {
    "ts": null,
    "headline": "Tuesday's big stock stories: What’s likely to move the market in the next trading session",
    "summary": "The Dow Industrials touched an all-time high and closed at a record Monday after the U.S. captured Venezuela's president over the weekend.",
    "url": "https://finnhub.io/api/news?id=f61c6a26cf5f64df9f3ec20ba5d7ce27364cfa8830aeb0ac94abd8d0161590fa",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767641062,
      "headline": "Tuesday's big stock stories: What’s likely to move the market in the next trading session",
      "id": 138001504,
      "image": "https://image.cnbcfm.com/api/v1/image/108234595-1764612176675-gettyimages-2236344491-COSTCO_EARNS.jpeg?v=1764612277&w=1920&h=1080",
      "related": "JPM",
      "source": "CNBC",
      "summary": "The Dow Industrials touched an all-time high and closed at a record Monday after the U.S. captured Venezuela's president over the weekend.",
      "url": "https://finnhub.io/api/news?id=f61c6a26cf5f64df9f3ec20ba5d7ce27364cfa8830aeb0ac94abd8d0161590fa"
    }
  },
  {
    "ts": null,
    "headline": "Sector Update: Financial Stocks Rise in Afternoon Trading",
    "summary": "Financial stocks were advancing in Monday afternoon trading, with the NYSE Financial Index rising 2.",
    "url": "https://finnhub.io/api/news?id=28e7d8f05cdfba7ce6c54776becb8272f240b5b3c282fdc731fea18ef3bd9c3d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767640658,
      "headline": "Sector Update: Financial Stocks Rise in Afternoon Trading",
      "id": 137997660,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "Financial stocks were advancing in Monday afternoon trading, with the NYSE Financial Index rising 2.",
      "url": "https://finnhub.io/api/news?id=28e7d8f05cdfba7ce6c54776becb8272f240b5b3c282fdc731fea18ef3bd9c3d"
    }
  },
  {
    "ts": null,
    "headline": "Novo Nordisk launches GLP-1 pill, bank stocks rally",
    "summary": "Yahoo Finance host Josh Lipton tracks today's top moving stocks and biggest market stories in this Market Minute, including Novo Nordisk (NVO) shares rising after the pharmaceutical prepares to launch its oral GLP-1 weight-loss pill while major bank stocks rally to new intraday record highs. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.",
    "url": "https://finnhub.io/api/news?id=387542902a94dd6841f1902ace552ccf11051d7a3fc3341b990f62fc8d01da35",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767640151,
      "headline": "Novo Nordisk launches GLP-1 pill, bank stocks rally",
      "id": 137997661,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "Yahoo Finance host Josh Lipton tracks today's top moving stocks and biggest market stories in this Market Minute, including Novo Nordisk (NVO) shares rising after the pharmaceutical prepares to launch its oral GLP-1 weight-loss pill while major bank stocks rally to new intraday record highs. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.",
      "url": "https://finnhub.io/api/news?id=387542902a94dd6841f1902ace552ccf11051d7a3fc3341b990f62fc8d01da35"
    }
  },
  {
    "ts": null,
    "headline": "Final Trade: NVO, JPM, COST, MPC",
    "summary": "The final trades of the day with CNBC's Melissa Lee and the 'Fast Money' traders.",
    "url": "https://finnhub.io/api/news?id=8dc9e00de5d82ddcdef98cc5b0fd102c18e922f0e874019673222a7cabd7df26",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767636149,
      "headline": "Final Trade: NVO, JPM, COST, MPC",
      "id": 138001506,
      "image": "https://image.cnbcfm.com/api/v1/image/108248512-17676540271767654025-43348875041-1080pnbcnews.jpg?v=1767654026&w=1920&h=1080",
      "related": "JPM",
      "source": "CNBC",
      "summary": "The final trades of the day with CNBC's Melissa Lee and the 'Fast Money' traders.",
      "url": "https://finnhub.io/api/news?id=8dc9e00de5d82ddcdef98cc5b0fd102c18e922f0e874019673222a7cabd7df26"
    }
  },
  {
    "ts": null,
    "headline": "The Dow Is Headed for a Record Close",
    "summary": "The Dow Jones Industrial Average is headed for its first all-time high of 2026—and is on pace to close above 49000 for the first-time on record. The index was up more than 1.5% in midday trading, thanks to a jump in shares of Chevron, the sole remaining U.",
    "url": "https://finnhub.io/api/news?id=35be788286229b4219a7b9f3c91a8139ee7ecda4ccfdb559574b20c0d557a9b4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767634814,
      "headline": "The Dow Is Headed for a Record Close",
      "id": 137993612,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "The Dow Jones Industrial Average is headed for its first all-time high of 2026—and is on pace to close above 49000 for the first-time on record. The index was up more than 1.5% in midday trading, thanks to a jump in shares of Chevron, the sole remaining U.",
      "url": "https://finnhub.io/api/news?id=35be788286229b4219a7b9f3c91a8139ee7ecda4ccfdb559574b20c0d557a9b4"
    }
  },
  {
    "ts": null,
    "headline": "Financial Stocks Poised for Record as JPMorgan Nears Milestone Closing Price",
    "summary": "The S&P 500’s financials sector was on track for a record closing high on Monday as investors appeared to find more opportunities than risk in the wake of the Trump administration’s intervention in Venezuela.  JPMorgan Chase, the largest U.S. lender by assets and the second-largest component of the financials sector index after Warren Buffett’s Berkshire Hathaway, jumped 3.3%.  Jamie Dimon’s JPMorgan was on pace to close above a market cap of $900 billion for the first time on record, according to Dow Jones Market Data.",
    "url": "https://finnhub.io/api/news?id=df607e3ffebb75817fcc3cb17391df4474c7594326c334364a68df1a45dea666",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767634424,
      "headline": "Financial Stocks Poised for Record as JPMorgan Nears Milestone Closing Price",
      "id": 137993266,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "The S&P 500’s financials sector was on track for a record closing high on Monday as investors appeared to find more opportunities than risk in the wake of the Trump administration’s intervention in Venezuela.  JPMorgan Chase, the largest U.S. lender by assets and the second-largest component of the financials sector index after Warren Buffett’s Berkshire Hathaway, jumped 3.3%.  Jamie Dimon’s JPMorgan was on pace to close above a market cap of $900 billion for the first time on record, according to Dow Jones Market Data.",
      "url": "https://finnhub.io/api/news?id=df607e3ffebb75817fcc3cb17391df4474c7594326c334364a68df1a45dea666"
    }
  },
  {
    "ts": null,
    "headline": "Top Midday Stories: Oil Stocks Rise After US Attack on Venezuela; QXO Receives $1.2 Billion Investment From Apollo-Affiliated Funds",
    "summary": "All three major US stock indexes rose in late-morning trading Monday as investors weighed the US att",
    "url": "https://finnhub.io/api/news?id=818deff1a8c4662dcb5777922e7b987b27f7b767cc6c6bd4e5d8e27e9f6c7786",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767632501,
      "headline": "Top Midday Stories: Oil Stocks Rise After US Attack on Venezuela; QXO Receives $1.2 Billion Investment From Apollo-Affiliated Funds",
      "id": 137992401,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "All three major US stock indexes rose in late-morning trading Monday as investors weighed the US att",
      "url": "https://finnhub.io/api/news?id=818deff1a8c4662dcb5777922e7b987b27f7b767cc6c6bd4e5d8e27e9f6c7786"
    }
  },
  {
    "ts": null,
    "headline": "Market Awaits Labor Market Reports",
    "summary": "Market Awaits Labor Market Reports.",
    "url": "https://finnhub.io/api/news?id=5820115773e552a3e6bd26fe48d0ecd1aea93664f862501017caa8527a870be4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767629280,
      "headline": "Market Awaits Labor Market Reports",
      "id": 137993267,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "Market Awaits Labor Market Reports.",
      "url": "https://finnhub.io/api/news?id=5820115773e552a3e6bd26fe48d0ecd1aea93664f862501017caa8527a870be4"
    }
  },
  {
    "ts": null,
    "headline": "Zealand Pharma to present at the J.P. Morgan Healthcare Conference",
    "summary": "Press release – No. 1 / 2026 Zealand Pharma to present at the J.P. Morgan Healthcare Conference Copenhagen, Denmark, January 5, 2026 – Zealand Pharma A/S (\"the Company\" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future of metabolic health, today announced that the Company will participate in the 44th J.P. Morgan Healthcare Conference on January 12-15, 2026 in San Francisco, California. Adam Steensberg, President and Chief Executive Officer, w",
    "url": "https://finnhub.io/api/news?id=d1b3b9f8396e188361035d6f69c72c2419da10da2df7ac08d2984aae6aed63a7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767629100,
      "headline": "Zealand Pharma to present at the J.P. Morgan Healthcare Conference",
      "id": 137991951,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "Press release – No. 1 / 2026 Zealand Pharma to present at the J.P. Morgan Healthcare Conference Copenhagen, Denmark, January 5, 2026 – Zealand Pharma A/S (\"the Company\" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future of metabolic health, today announced that the Company will participate in the 44th J.P. Morgan Healthcare Conference on January 12-15, 2026 in San Francisco, California. Adam Steensberg, President and Chief Executive Officer, w",
      "url": "https://finnhub.io/api/news?id=d1b3b9f8396e188361035d6f69c72c2419da10da2df7ac08d2984aae6aed63a7"
    }
  },
  {
    "ts": null,
    "headline": "Jamie Dimon warns of major ‘turbulence’ hitting US stocks driven by tariff inflation. How to ‘crashproof’ your nest egg",
    "summary": "And he's not alone.",
    "url": "https://finnhub.io/api/news?id=cebd94e8b4c4b66ba1b05739100e3b0025beab62ea34050e6a2517e7b330a772",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767628860,
      "headline": "Jamie Dimon warns of major ‘turbulence’ hitting US stocks driven by tariff inflation. How to ‘crashproof’ your nest egg",
      "id": 137991952,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "And he's not alone.",
      "url": "https://finnhub.io/api/news?id=cebd94e8b4c4b66ba1b05739100e3b0025beab62ea34050e6a2517e7b330a772"
    }
  },
  {
    "ts": null,
    "headline": "Encoded Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026",
    "summary": "SOUTH SAN FRANCISCO, Calif., January 05, 2026--Encoded Therapeutics Inc., a clinical-stage biotechnology company developing genetic medicines for severe neurological disorders, today announced that Kartik Ramamoorthi, Ph.D., Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 5:30 p.m. PT in San Francisco, California.",
    "url": "https://finnhub.io/api/news?id=f993c3e431da1d241433fdbeddb868ac395676b08e78412ecb72336e8289dbd0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767628800,
      "headline": "Encoded Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026",
      "id": 137991953,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "SOUTH SAN FRANCISCO, Calif., January 05, 2026--Encoded Therapeutics Inc., a clinical-stage biotechnology company developing genetic medicines for severe neurological disorders, today announced that Kartik Ramamoorthi, Ph.D., Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 5:30 p.m. PT in San Francisco, California.",
      "url": "https://finnhub.io/api/news?id=f993c3e431da1d241433fdbeddb868ac395676b08e78412ecb72336e8289dbd0"
    }
  },
  {
    "ts": null,
    "headline": "My Dividend Stock Portfolio: New November Dividend Record - 100 Holdings With 12 Buys",
    "summary": "Read about the latest moves in my dividend stock portfolio and why I trimmed NVDA/AMD on valuation and rotated into BDCs (ARCC, OBDC, HTGC) for yield.",
    "url": "https://finnhub.io/api/news?id=c7d57cc52fce12c1c1fb6836f77982bdb9233d7d33af4280465110aaef63946d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767628048,
      "headline": "My Dividend Stock Portfolio: New November Dividend Record - 100 Holdings With 12 Buys",
      "id": 137994613,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1213764535/image_1213764535.jpg?io=getty-c-w1536",
      "related": "JPM",
      "source": "SeekingAlpha",
      "summary": "Read about the latest moves in my dividend stock portfolio and why I trimmed NVDA/AMD on valuation and rotated into BDCs (ARCC, OBDC, HTGC) for yield.",
      "url": "https://finnhub.io/api/news?id=c7d57cc52fce12c1c1fb6836f77982bdb9233d7d33af4280465110aaef63946d"
    }
  },
  {
    "ts": null,
    "headline": "Looking Ahead to a New \"Jobs Week\"",
    "summary": "\"Jobs Week\" starts Wednesday with ADP private-sector payrolls and JOLTS numbers, and ends Friday with the full BLS report.",
    "url": "https://finnhub.io/api/news?id=8d67040ab413dec9f15017b55377f4dc2c08800db34d043fe08c6d77ad21e802",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767627000,
      "headline": "Looking Ahead to a New \"Jobs Week\"",
      "id": 137992404,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "\"Jobs Week\" starts Wednesday with ADP private-sector payrolls and JOLTS numbers, and ends Friday with the full BLS report.",
      "url": "https://finnhub.io/api/news?id=8d67040ab413dec9f15017b55377f4dc2c08800db34d043fe08c6d77ad21e802"
    }
  },
  {
    "ts": null,
    "headline": "Bitcoin miners continue to face dwindling profits despite lower competition, JPMorgan says",
    "summary": "Mining profitability declined last month, with daily block reward revenue down 7%, and 32% year-on-year.",
    "url": "https://finnhub.io/api/news?id=e6805925a4b3f548c34a36ae8069eb82aab7b68c306ee49bed045ef8b7fa5fb4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767625299,
      "headline": "Bitcoin miners continue to face dwindling profits despite lower competition, JPMorgan says",
      "id": 137992847,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "Mining profitability declined last month, with daily block reward revenue down 7%, and 32% year-on-year.",
      "url": "https://finnhub.io/api/news?id=e6805925a4b3f548c34a36ae8069eb82aab7b68c306ee49bed045ef8b7fa5fb4"
    }
  },
  {
    "ts": null,
    "headline": "Citigroup: Priced For Perfection, But More Cuts Can Be Made",
    "summary": "Citigroup Inc. now trades in line with money center banks and looks priced for perfection as forecasts stay aggressive. Click for this C earnings preview.",
    "url": "https://finnhub.io/api/news?id=0b93dfd4b440be8e2a788773b4faa9e78469288bfe24476cdf0d9fa23271e390",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767624697,
      "headline": "Citigroup: Priced For Perfection, But More Cuts Can Be Made",
      "id": 137994204,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/508352863/image_508352863.jpg?io=getty-c-w1536",
      "related": "JPM",
      "source": "SeekingAlpha",
      "summary": "Citigroup Inc. now trades in line with money center banks and looks priced for perfection as forecasts stay aggressive. Click for this C earnings preview.",
      "url": "https://finnhub.io/api/news?id=0b93dfd4b440be8e2a788773b4faa9e78469288bfe24476cdf0d9fa23271e390"
    }
  },
  {
    "ts": null,
    "headline": "3 Income ETFs With the Stability to Last the Next Decade",
    "summary": "One of the most important things to remember is that if you want to build up wealth, it’s different than retirement income, and if you’re on the former side, you want to start accumulating money now. If you’re trying to live off your portfolio now, volatility can become highly personal, as a 20% drop in ... 3 Income ETFs With the Stability to Last the Next Decade",
    "url": "https://finnhub.io/api/news?id=bd17c2d1db806a54c707f0ac9a098f012d7b06c3dad690231a3b8c5efd90c352",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767623234,
      "headline": "3 Income ETFs With the Stability to Last the Next Decade",
      "id": 137990985,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "One of the most important things to remember is that if you want to build up wealth, it’s different than retirement income, and if you’re on the former side, you want to start accumulating money now. If you’re trying to live off your portfolio now, volatility can become highly personal, as a 20% drop in ... 3 Income ETFs With the Stability to Last the Next Decade",
      "url": "https://finnhub.io/api/news?id=bd17c2d1db806a54c707f0ac9a098f012d7b06c3dad690231a3b8c5efd90c352"
    }
  },
  {
    "ts": null,
    "headline": "Alnylam to Webcast Presentation at 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "CAMBRIDGE, Mass., January 05, 2026--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview and participate in a Q&A session at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 9:00 am PT (12:00 pm ET) at The Westin St. Francis in San Francisco. During the presentation, the Company will unveil its new five-year strategy, which will guide the Company’s next phase of growth.",
    "url": "https://finnhub.io/api/news?id=aebd450f8b55d84a8ac7c1db909f603494169d02d557ffef96682e7f91548a83",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767622500,
      "headline": "Alnylam to Webcast Presentation at 44th Annual J.P. Morgan Healthcare Conference",
      "id": 137990986,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "CAMBRIDGE, Mass., January 05, 2026--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview and participate in a Q&A session at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 9:00 am PT (12:00 pm ET) at The Westin St. Francis in San Francisco. During the presentation, the Company will unveil its new five-year strategy, which will guide the Company’s next phase of growth.",
      "url": "https://finnhub.io/api/news?id=aebd450f8b55d84a8ac7c1db909f603494169d02d557ffef96682e7f91548a83"
    }
  },
  {
    "ts": null,
    "headline": "CRISPR Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "ZUG, Switzerland and BOSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 8:15 a.m. PT in San Francisco. A live webcast of the presentation will be available on the \"Events & Presentations\" page in the Investors s",
    "url": "https://finnhub.io/api/news?id=abbd2c229d501021e4af0fc724a1a08155d60d7b13ea320b49c6ceba1fa9bb61",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767619800,
      "headline": "CRISPR Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference",
      "id": 137990988,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "ZUG, Switzerland and BOSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 8:15 a.m. PT in San Francisco. A live webcast of the presentation will be available on the \"Events & Presentations\" page in the Investors s",
      "url": "https://finnhub.io/api/news?id=abbd2c229d501021e4af0fc724a1a08155d60d7b13ea320b49c6ceba1fa9bb61"
    }
  },
  {
    "ts": null,
    "headline": "Sarepta Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "CAMBRIDGE, Mass., January 05, 2026--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, Calif. on Monday, Jan. 12, 2026 at 12:00 p.m. E.T. / 9:00 a.m. P.T. Following the presentation there will be a Q&A session starting at 12:20 p.m. E.T. / 9:20 a.m. P.T.",
    "url": "https://finnhub.io/api/news?id=de2a58f647c37696c6f231b211a207a033604d46b6d7589f7aa29f7b301b8036",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767619800,
      "headline": "Sarepta Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference",
      "id": 137990987,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "CAMBRIDGE, Mass., January 05, 2026--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, Calif. on Monday, Jan. 12, 2026 at 12:00 p.m. E.T. / 9:00 a.m. P.T. Following the presentation there will be a Q&A session starting at 12:20 p.m. E.T. / 9:20 a.m. P.T.",
      "url": "https://finnhub.io/api/news?id=de2a58f647c37696c6f231b211a207a033604d46b6d7589f7aa29f7b301b8036"
    }
  },
  {
    "ts": null,
    "headline": "Star Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12",
    "summary": "SOUTH SAN FRANCISCO, Calif., January 05, 2026--Star Therapeutics, a late clinical-stage biotechnology company discovering and developing best-in-class antibodies for bleeding disorders and other diseases, today announced that Adam Rosenthal, Ph.D., CEO and Founder, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 4:30 p.m. PT in San Francisco, CA.",
    "url": "https://finnhub.io/api/news?id=d501c88dbb9aed341bf6b98346fb01c8e4c54a597072248aae9b544d4442749b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767618000,
      "headline": "Star Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12",
      "id": 137990993,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "SOUTH SAN FRANCISCO, Calif., January 05, 2026--Star Therapeutics, a late clinical-stage biotechnology company discovering and developing best-in-class antibodies for bleeding disorders and other diseases, today announced that Adam Rosenthal, Ph.D., CEO and Founder, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 4:30 p.m. PT in San Francisco, CA.",
      "url": "https://finnhub.io/api/news?id=d501c88dbb9aed341bf6b98346fb01c8e4c54a597072248aae9b544d4442749b"
    }
  },
  {
    "ts": null,
    "headline": "BlossomHill Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12",
    "summary": "SAN DIEGO, Jan. 05, 2026 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc., a privately-held, clinical-stage biopharmaceutical company focused on the design and development of next-generation medicines for cancer, today announced the company will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 2:00 p.m. PT. J. Jean Cui, Ph.D., President & Chief Executive Officer, and Geoff Oxnard, M.D., Chief Medical Officer, will provide an overview of the company’s",
    "url": "https://finnhub.io/api/news?id=e795c3077b38b49e4a2204eb73c742bbba71761e1ec1e0a639dc8db33bfd0e8e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767618000,
      "headline": "BlossomHill Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12",
      "id": 137990992,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "SAN DIEGO, Jan. 05, 2026 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc., a privately-held, clinical-stage biopharmaceutical company focused on the design and development of next-generation medicines for cancer, today announced the company will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 2:00 p.m. PT. J. Jean Cui, Ph.D., President & Chief Executive Officer, and Geoff Oxnard, M.D., Chief Medical Officer, will provide an overview of the company’s",
      "url": "https://finnhub.io/api/news?id=e795c3077b38b49e4a2204eb73c742bbba71761e1ec1e0a639dc8db33bfd0e8e"
    }
  },
  {
    "ts": null,
    "headline": "Esperion to Participate in Upcoming 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "ANN ARBOR, Mich., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will present at J.P. Morgan’s 44th Annual Healthcare Conference on Wednesday, January 14, 2025. The company’s presentation and participation in a fireside chat will begin at 2:15 p.m. PT/5:15 p.m. ET. The live webcast can be accessed on the investor and media section of the Esperion website. Access to the webcast replay will be available approximately two hours after the completion of the",
    "url": "https://finnhub.io/api/news?id=2dc4eea4014e64636c9a2e63e6562a0985c7476b5a5374bb5af7cbba5209edc4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767618000,
      "headline": "Esperion to Participate in Upcoming 44th Annual J.P. Morgan Healthcare Conference",
      "id": 137990991,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "ANN ARBOR, Mich., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will present at J.P. Morgan’s 44th Annual Healthcare Conference on Wednesday, January 14, 2025. The company’s presentation and participation in a fireside chat will begin at 2:15 p.m. PT/5:15 p.m. ET. The live webcast can be accessed on the investor and media section of the Esperion website. Access to the webcast replay will be available approximately two hours after the completion of the",
      "url": "https://finnhub.io/api/news?id=2dc4eea4014e64636c9a2e63e6562a0985c7476b5a5374bb5af7cbba5209edc4"
    }
  },
  {
    "ts": null,
    "headline": "Circle Pharma to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "SOUTH SAN FRANCISCO, Calif., January 05, 2026--Circle Pharma, Inc., a clinical-stage biopharmaceutical company pioneering next-generation targeted macrocycle therapeutics for cancer, today announced that David J. Earp, J.D., Ph.D., president and chief executive officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 5:00 p.m. PT.",
    "url": "https://finnhub.io/api/news?id=da084b5eaaf32d57a8faad0be235a1c610a9e6d49f6ffdb3f16940d5d1320fa9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767618000,
      "headline": "Circle Pharma to Present at the 44th Annual J.P. Morgan Healthcare Conference",
      "id": 137990990,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "SOUTH SAN FRANCISCO, Calif., January 05, 2026--Circle Pharma, Inc., a clinical-stage biopharmaceutical company pioneering next-generation targeted macrocycle therapeutics for cancer, today announced that David J. Earp, J.D., Ph.D., president and chief executive officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 5:00 p.m. PT.",
      "url": "https://finnhub.io/api/news?id=da084b5eaaf32d57a8faad0be235a1c610a9e6d49f6ffdb3f16940d5d1320fa9"
    }
  },
  {
    "ts": null,
    "headline": "Scholar Rock to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "CAMBRIDGE, Mass., January 05, 2026--Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to dramatically improving the lives of children and adults with spinal muscular atrophy (SMA) and additional rare, severe, and debilitating neuromuscular diseases by applying its leading platform in myostatin biology to advance musculoskeletal health, today announced that management will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12 at 7:30 a.m. PST (",
    "url": "https://finnhub.io/api/news?id=6728ac16440772334719dcf1eaba39693efd8994fc5377a5665c420c378d78ce",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767618000,
      "headline": "Scholar Rock to Present at the 44th Annual J.P. Morgan Healthcare Conference",
      "id": 137990989,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "CAMBRIDGE, Mass., January 05, 2026--Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to dramatically improving the lives of children and adults with spinal muscular atrophy (SMA) and additional rare, severe, and debilitating neuromuscular diseases by applying its leading platform in myostatin biology to advance musculoskeletal health, today announced that management will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12 at 7:30 a.m. PST (",
      "url": "https://finnhub.io/api/news?id=6728ac16440772334719dcf1eaba39693efd8994fc5377a5665c420c378d78ce"
    }
  },
  {
    "ts": null,
    "headline": "Corbus Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "NORWOOD, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP), a clinical-stage company focused on oncology and obesity, today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will present a corporate overview at the 2026 Annual J.P. Morgan Healthcare Conference, to be held January 12-15, 2026, in San Francisco, CA. 44th Annual J.P. Morgan Healthcare Conference Format: Presentation and one-on-one investor meetings Date: January 15, 202",
    "url": "https://finnhub.io/api/news?id=c15a2a6013551c12ba00bfc37f0c42801d5069458d0441de3f8d58515ae2ed03",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767616200,
      "headline": "Corbus Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference",
      "id": 137990995,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "NORWOOD, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP), a clinical-stage company focused on oncology and obesity, today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will present a corporate overview at the 2026 Annual J.P. Morgan Healthcare Conference, to be held January 12-15, 2026, in San Francisco, CA. 44th Annual J.P. Morgan Healthcare Conference Format: Presentation and one-on-one investor meetings Date: January 15, 202",
      "url": "https://finnhub.io/api/news?id=c15a2a6013551c12ba00bfc37f0c42801d5069458d0441de3f8d58515ae2ed03"
    }
  },
  {
    "ts": null,
    "headline": "Neurogene to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "NEW YORK, January 05, 2026--Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that Company management will participate in the 44th Annual J.P. Morgan Healthcare Conference.",
    "url": "https://finnhub.io/api/news?id=7176ba5a6c222f73d8cc268ce6c91e55bb5e4a70980caa00fba280c3ce4d0d9b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767616200,
      "headline": "Neurogene to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
      "id": 137990994,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "NEW YORK, January 05, 2026--Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that Company management will participate in the 44th Annual J.P. Morgan Healthcare Conference.",
      "url": "https://finnhub.io/api/news?id=7176ba5a6c222f73d8cc268ce6c91e55bb5e4a70980caa00fba280c3ce4d0d9b"
    }
  },
  {
    "ts": null,
    "headline": "NeoGenomics to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "FORT MYERS, Fla., January 05, 2026--NeoGenomics will participate in the upcoming 44th Annual J.P. Morgan Healthcare Conference in San Francisco.",
    "url": "https://finnhub.io/api/news?id=322b4c340f7398d2c8b6393979db7e4385251c132ce00a89b691e49887fdf15b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767614700,
      "headline": "NeoGenomics to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
      "id": 137990996,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "FORT MYERS, Fla., January 05, 2026--NeoGenomics will participate in the upcoming 44th Annual J.P. Morgan Healthcare Conference in San Francisco.",
      "url": "https://finnhub.io/api/news?id=322b4c340f7398d2c8b6393979db7e4385251c132ce00a89b691e49887fdf15b"
    }
  },
  {
    "ts": null,
    "headline": "Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "CRANBURY, N.J., January 05, 2026--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced that the Company will participate in the 44th Annual J.P. Morgan Healthcare Conference, in San Francisco. Gaurav Shah, M.D., Chief Executive Officer, is scheduled to present on Wednesday, January 14, at 11:15 a.m. PT and host investor meetings throughout th",
    "url": "https://finnhub.io/api/news?id=40bd2c6482ee742b61fac91f61f0a5cb1b3970c7055975d41dc781d13e945aa1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767614400,
      "headline": "Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference",
      "id": 137991004,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "CRANBURY, N.J., January 05, 2026--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced that the Company will participate in the 44th Annual J.P. Morgan Healthcare Conference, in San Francisco. Gaurav Shah, M.D., Chief Executive Officer, is scheduled to present on Wednesday, January 14, at 11:15 a.m. PT and host investor meetings throughout th",
      "url": "https://finnhub.io/api/news?id=40bd2c6482ee742b61fac91f61f0a5cb1b3970c7055975d41dc781d13e945aa1"
    }
  },
  {
    "ts": null,
    "headline": "Nanoscope Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel, disease-agnostic therapies for patients with photoreceptor loss and vision impairment due to retinal degeneration, announced today that Sulagna Bhattacharya, Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12th, 2026 from 11:30 to 11:55 AM PST.",
    "url": "https://finnhub.io/api/news?id=711fd4599d3b6f952e5599520790421e300817ff934d6f8e0ddf2066130c0926",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767614400,
      "headline": "Nanoscope Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference",
      "id": 137991003,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel, disease-agnostic therapies for patients with photoreceptor loss and vision impairment due to retinal degeneration, announced today that Sulagna Bhattacharya, Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12th, 2026 from 11:30 to 11:55 AM PST.",
      "url": "https://finnhub.io/api/news?id=711fd4599d3b6f952e5599520790421e300817ff934d6f8e0ddf2066130c0926"
    }
  },
  {
    "ts": null,
    "headline": "Sionna Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "WALTHAM, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein, today announced that management will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13th, 2026 at 9:45 a.m. PT/1",
    "url": "https://finnhub.io/api/news?id=50ebe39bee699bcabca05d63c5462ad3c31938c9ce39b951971c8aae90b074ec",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767614400,
      "headline": "Sionna Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference",
      "id": 137991002,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "WALTHAM, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein, today announced that management will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13th, 2026 at 9:45 a.m. PT/1",
      "url": "https://finnhub.io/api/news?id=50ebe39bee699bcabca05d63c5462ad3c31938c9ce39b951971c8aae90b074ec"
    }
  },
  {
    "ts": null,
    "headline": "Agios to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026",
    "summary": "CAMBRIDGE, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today announced that its management team is scheduled to present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, at 8:15 a.m. PST / 11:15 a.m. EST. The live webcast will be accessible on the Investors section of the company's website (www.agios.c",
    "url": "https://finnhub.io/api/news?id=c73c5fe909bbafb36f9799f1b6c550f887067463d36a5b5c00ee7632b3a724ee",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767614400,
      "headline": "Agios to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026",
      "id": 137991001,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "CAMBRIDGE, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today announced that its management team is scheduled to present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, at 8:15 a.m. PST / 11:15 a.m. EST. The live webcast will be accessible on the Investors section of the company's website (www.agios.c",
      "url": "https://finnhub.io/api/news?id=c73c5fe909bbafb36f9799f1b6c550f887067463d36a5b5c00ee7632b3a724ee"
    }
  },
  {
    "ts": null,
    "headline": "Apellis Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "WALTHAM, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 11:15 a.m. PT. The live conference webcast will be posted on the “Events and Presentations” page of the “Investors and Media” section of the company’s website. A replay of the webcast will be available for approximately 90 days following the event. About ApellisApellis Phar",
    "url": "https://finnhub.io/api/news?id=850402111cf24c32b367b346f6b85effe458f1a4722f79ccc0a588fe89bc4ca1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767614400,
      "headline": "Apellis Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference",
      "id": 137991000,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "WALTHAM, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 11:15 a.m. PT. The live conference webcast will be posted on the “Events and Presentations” page of the “Investors and Media” section of the company’s website. A replay of the webcast will be available for approximately 90 days following the event. About ApellisApellis Phar",
      "url": "https://finnhub.io/api/news?id=850402111cf24c32b367b346f6b85effe458f1a4722f79ccc0a588fe89bc4ca1"
    }
  },
  {
    "ts": null,
    "headline": "Enanta Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "WATERTOWN, Mass., January 05, 2026--Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs with an emphasis on treatments for viral infections and immunological diseases, today announced that Jay R. Luly, Ph.D., Enanta’s President and Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 3:00 p.m. PT in San Francisco, CA.",
    "url": "https://finnhub.io/api/news?id=7b3f7cf01a93fb146e1d7ba3f394c89d9fef515f44f7e84307dcf282353d7ba4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767614400,
      "headline": "Enanta Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference",
      "id": 137990999,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "WATERTOWN, Mass., January 05, 2026--Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs with an emphasis on treatments for viral infections and immunological diseases, today announced that Jay R. Luly, Ph.D., Enanta’s President and Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 3:00 p.m. PT in San Francisco, CA.",
      "url": "https://finnhub.io/api/news?id=7b3f7cf01a93fb146e1d7ba3f394c89d9fef515f44f7e84307dcf282353d7ba4"
    }
  },
  {
    "ts": null,
    "headline": "United Therapeutics Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "SILVER SPRING, Md. & DURHAM, N.C., January 05, 2026--United Therapeutics Corporation (Nasdaq: UTHR) announced today that Dr. Martine Rothblatt, Chairperson and Chief Executive Officer, will present a company overview and update on Monday, January 12, 2026, from 1:30 to 2:10 p.m. PST, at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco.",
    "url": "https://finnhub.io/api/news?id=dce994b4364a61fd1d96259a89a68e395aa389d4b95590fb51b32d07f9ff45b2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767614400,
      "headline": "United Therapeutics Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference",
      "id": 137990998,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "SILVER SPRING, Md. & DURHAM, N.C., January 05, 2026--United Therapeutics Corporation (Nasdaq: UTHR) announced today that Dr. Martine Rothblatt, Chairperson and Chief Executive Officer, will present a company overview and update on Monday, January 12, 2026, from 1:30 to 2:10 p.m. PST, at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco.",
      "url": "https://finnhub.io/api/news?id=dce994b4364a61fd1d96259a89a68e395aa389d4b95590fb51b32d07f9ff45b2"
    }
  },
  {
    "ts": null,
    "headline": "Seaport Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference",
    "summary": "BOSTON, January 05, 2026--Seaport Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference.",
    "url": "https://finnhub.io/api/news?id=89f9abd1df9d42d52b90168a2a1fca24561769bb6f3db03c9efaa4a2ef85d64d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767614400,
      "headline": "Seaport Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference",
      "id": 137990997,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JPM",
      "source": "Yahoo",
      "summary": "BOSTON, January 05, 2026--Seaport Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference.",
      "url": "https://finnhub.io/api/news?id=89f9abd1df9d42d52b90168a2a1fca24561769bb6f3db03c9efaa4a2ef85d64d"
    }
  },
  {
    "ts": null,
    "headline": "Last call: $250 Amazon Prime Visa bonus ending soon",
    "summary": "If you're a Prime member, this is the best rewards card for saving on Amazon purchases.",
    "url": "https://finnhub.io/api/news?id=560ae8927cb0d60967a6d160e3d0d7df77f7a129787cc351fed9eaa8cd6d13c6",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767612050,
      "headline": "Last call: $250 Amazon Prime Visa bonus ending soon",
      "id": 137992601,
      "image": "https://image.cnbcfm.com/api/v1/image/108247411-1767357883951-gettyimages-1414719403-gjor_5949copy.jpeg?v=1767357906&w=1920&h=1080",
      "related": "JPM",
      "source": "CNBC",
      "summary": "If you're a Prime member, this is the best rewards card for saving on Amazon purchases.",
      "url": "https://finnhub.io/api/news?id=560ae8927cb0d60967a6d160e3d0d7df77f7a129787cc351fed9eaa8cd6d13c6"
    }
  },
  {
    "ts": null,
    "headline": "JPMorgan forms special advisory group to share some of bank's 'secret sauce' with clients",
    "summary": "They're calling the initiative the \"Special Advisory Services,\" which launches Monday, with Liz Myers, who also serves as global chair of investment banking, at the helm.",
    "url": "https://finnhub.io/api/news?id=a3ccae8956547f64ba9efd0130b2955543f57c929cf44d5d7e94535c4e70c2ed",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767605402,
      "headline": "JPMorgan forms special advisory group to share some of bank's 'secret sauce' with clients",
      "id": 137992660,
      "image": "https://image.cnbcfm.com/api/v1/image/108234703-17646190402025-12-01t193705z_1610567590_rc2v7iafe0yc_rtrmadp_0_jpmorgan-chase-results.jpeg?v=1764619122&w=1920&h=1080",
      "related": "JPM",
      "source": "CNBC",
      "summary": "They're calling the initiative the \"Special Advisory Services,\" which launches Monday, with Liz Myers, who also serves as global chair of investment banking, at the helm.",
      "url": "https://finnhub.io/api/news?id=a3ccae8956547f64ba9efd0130b2955543f57c929cf44d5d7e94535c4e70c2ed"
    }
  },
  {
    "ts": null,
    "headline": "Cramer’s Mad Dash: JPMorgan Chase",
    "summary": "CNBC’s Jim Cramer delivers his daily Mad Dash.",
    "url": "https://finnhub.io/api/news?id=d589fb98d81dffcb1a1e487f884fc01dcbb32a2fd6d71caad7b481c7e4d64acd",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767605212,
      "headline": "Cramer’s Mad Dash: JPMorgan Chase",
      "id": 137992661,
      "image": "https://image.cnbcfm.com/api/v1/image/108248112-17676230711767623068-43342616799-1080pnbcnews.jpg?v=1767623070&w=1920&h=1080",
      "related": "JPM",
      "source": "CNBC",
      "summary": "CNBC’s Jim Cramer delivers his daily Mad Dash.",
      "url": "https://finnhub.io/api/news?id=d589fb98d81dffcb1a1e487f884fc01dcbb32a2fd6d71caad7b481c7e4d64acd"
    }
  },
  {
    "ts": null,
    "headline": "CNBC Daily Open: Investors had much to cheer in 2025 — but 2026's starting out rocky",
    "summary": "The S&P 500 rallied 16.39% in 2025, mostly on the back of enthusiasm over AI. But investors have to contend with the U.S.' attack on Venezuela.",
    "url": "https://finnhub.io/api/news?id=e47d755621d8014631c0f318555b7e041b84618e7e59f22f2a4d0132a398520b",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767580201,
      "headline": "CNBC Daily Open: Investors had much to cheer in 2025 — but 2026's starting out rocky",
      "id": 137992662,
      "image": "https://image.cnbcfm.com/api/v1/image/108247460-1767363849108-gettyimages-2253535817-US_STOCKS.jpeg?v=1767363882&w=1920&h=1080",
      "related": "JPM",
      "source": "CNBC",
      "summary": "The S&P 500 rallied 16.39% in 2025, mostly on the back of enthusiasm over AI. But investors have to contend with the U.S.' attack on Venezuela. ",
      "url": "https://finnhub.io/api/news?id=e47d755621d8014631c0f318555b7e041b84618e7e59f22f2a4d0132a398520b"
    }
  }
]